Pembrolizumab Versus Chemotherapy as Second-Line Therapy for Advanced Esophageal Cancer: Phase Iii Keynote-)181 Study.

AuthID
P-00R-4YX
20
Author(s)
Kojima, T
·
Francois, E
·
Kim, SB
·
Lee, SH
·
Bennouna, J
·
Kato, K
·
Lin, S
·
Qin, SQ
·
Ferreira, P
·
Adenis, A
·
Enzinger, PC
·
Shah, MA
·
Wang, RX
·
Kang, SP
·
Metges, JP
Document Type
Abstract
Year published
2019
Published
in JOURNAL OF CLINICAL ONCOLOGY, ISSN: 0732-183X
Volume: 37, Issue: 4
Conference
Gastrointestinal Cancers Symposium, Date: JAN 17-19, 2019, Location: San Francisco, CA
Indexing
Publication Identifiers
Wos: WOS:000489107600050
Source Identifiers
ISSN: 0732-183X
Export Publication Metadata
Marked List
Info
At this moment we don't have any links to full text documens.